Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose pharmacokinetic study of trantinterol hydrochloride tablets in elderly volunteers
ChiCTR-ONRC-14004800Phase 4Completed
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of trantinterol hydrochloride in asthma (2 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Trantinterol pharmacokinetics and 1-carbonyl trantinterol metabolite pharmacokinetics. Started May 2012; status: completed.
02
Drugs
trantinterol hydrochloride
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR-ONRC-14004800.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-14004800.